Comparison of drug eluting stent for treatment of early and late in-stent restenosis.

doi:10.7504/nk2014090405

Abstract

Abstract:

Abstract：Objective Compare the efficiency and safety of drug eluting stent (DES) for treatment of early and late in stent restenosis(ISR).Methods Patients treated with DES for ISR and de novo lesions in Beijing Anzhen Hospital between October 2008 and December 2011 were followed up for 1 year.All lesions were divided into early and late ISR group.Major adverse cardiovascular events (MACE) including all-cause death，myocardial infarction (MI) and clinical target lesion revascularization (TLR) were the primary endpoints.Results The study population consisted of 80 patients in early ISR group and 124 patients in late ISR group.Baseline clinical and angiographic parameters were comparable between the two groups.The rate of TLR in early ISR group was higher than that in late ISR group (26.3% to 12.1%，P<0.05)，contributing to higher MACE in early ISR group(30.0% vs 15.3%，P<0.01).Conclusion DES implantation is safe and effective for treatment of ISR lesions，but the rate of TLR for treatment of early ISR lesions is higher compared to treatment of late ISR lesions.

Key words: drug eluting stent, early in stent restenosis, late in stent restenosis, repeated revascularization

摘要：

目的比较药物洗脱支架(DES)治疗早期(≤1年)、晚期(＞1年)支架内再狭窄病变(ISR)患者的长期临床疗效。方法收集2008年10月至2011年12月在北京安贞医院因ISR接受DES置入治疗并完成临床随访的患者资料，根据DES术后发生ISR的时间是否大于1年分为早期ISR组与晚期组。比较两组组患者术后1年的主要不良心血管事件［MACE，包括全因死亡、心肌梗死(MI)和靶病变再次血运重建(TLR)］。结果早期ISR组入选患者80例，晚期ISR组入选患者124例。早期ISR组不稳定型心绞痛发生率明显低于晚期ISR组，差异有统计学意义(27.5%对63.7%，P<0.01)；其余基线资料差异无统计学意义(P>0.05)。两组在病变部位、病变类型、病变长度方面比较差异均无统计学意义(P>0.05)。早期ISR组MACE发生率明显高于晚期ISR组(30%对15.3%，P<0.01)，其中早期ISR组TLR明显高于晚期ISR组，差异有统计学意义(26.3%对12.1%，P<0.01)。结论 DES治疗ISR患者安全有效，但治疗早期ISR组病变TLR发生率高于晚期ISR组。

关键词: 药物洗脱支架, 早期支架内再狭窄, 晚期支架内再狭窄, 再次血运重建

CLC Number:

R541.4

ZHANG Yu-chen，ZHAO Lin，LI Yu，CHEN Fang. Comparison of drug eluting stent for treatment of early and late in-stent restenosis.[J]. Acta Metallurgica Sinica, DOI: 10.7504/nk2014090405.

张宇晨，赵林，李宇，陈方. 药物洗脱支架置入治疗不同时期冠状动脉支架内再狭窄对比研究[J]. 中国实用内科杂志, DOI: 10.7504/nk2014090405.

References



[1］Hikita H，Kuroda S，Kawaguchi N，et al.Differential characteristics of inflammatory responses to stent implantation between de novo and intrastent restenosis lesion in patients with stable angina［J］.Angiology，2012，63(2)：92-95. 

[2］Hao PP，Chen YG，Wang XI，et al.Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction：flmeta-analysis of randomized controlled trials［J］.Tex Hcart Inst，2010，37：516-524. 

[3］Suzuki S，Ishii H，Matsudaira K，et al.Long-Term Outcome of Drug-Eluting vs.Bare-Metal Stents in Patients With Acute Myocardial Infarction［J］.Circ J，2013，77(8)：2024-2031. 

[4］高展，杨跃进，陈纪林，等.药物洗脱支架治疗支架内再狭窄的对照研究［J］.中华内科杂志，2009，48(2)：122-125. 

[5］韩红亚，周玉杰.药物洗脱支架内血栓形成的防治策略［J］.郑州大学学报(医学版)，2009，44(1)：1-4. 

[6］Habara M，Terashima M，Nasu K，et al.Morphological differences of tissue characteristics between early，late，and very late restenosis lesions after first generation drug-eluting stent implantation：an optical coherence tomography study［J］.Eur Heart J Cardiovasc Imaging，2013，143：276-284. 

[7］Habara M，Terashima M，Nasu K，et al.Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation：an optical coherence tomography study［J］.Circ Cardiovasc Interv，2011，43：232-238. 

[8］Park SJ，Kang SJ，Virmani R，et al.In-stent neoatherosclerosis：a final common pathway of late stent failure［J］.J Am Coll Cardiol，2012，59(23)：2051-2057. 

[9］杨希立，张阳德，许兆延，等.血管内超声对经皮介入术后支架内再狭窄的评价［J］.南方医科大学学报 2008，28(10)：1914-1915，1918. 

[10］董剑廷，袁勇，张励庭，等.药物洗脱支架治疗冠状动脉支架内再狭窄的疗效［J］.南方医科大学学报，2006，26(8):1253-1254. 

[11］马长生，乔岩.急性心肌梗死患者应用药物洗脱支架的安全性和有效性评估［J］郑州大学学报(医学版)，2010，45(2)：173-176. 

[12］陈晖，施鸿毓，仇兴标，等.药物洗脱支架内再狭窄的介入治疗［J］.上海医学，2012，35(3)：216-219. 

[13］Almalla M，Schrder J，Pross V，et al.Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.Catheter Cardiovasc Interv,2014,83(6):881-887. 

[14］Kang SJ，Mintz GS，Akasaka T，et al.Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation［J］.Circulation，2011，28；123(25)：2954-2963. 

[15］余丹青，林曙光，陈纪言，等.血管内超声指导急性冠脉综合征临界病变介入治疗临床研究［J］.南方医科大学学报，2009，29(12)：2453-2455，2458. 

[16］刘灵芝，侯翠红，刘恒亮.冠脉内支架植入术后再狭窄的影响因素分析［J］.郑州大学学报(医学版)，2005，40(3)：533-535. 

[17］侯青，乔树宾，高润霖，等.冠状动脉支架术后再狭窄的预测因素［J］.中华心血管病杂志，2005，33(z1)：61-64. 

[18］Sato T，Ono T，Morimoto Y，et al.Differences in clinical and angiographic outcomes with different drug-eluting stents in Japanese patients with and without diabetes mellitus［J］.J Cardiol，2012，60(5)：361-366. 

[19］Rathore S，Kaul U.Percutaneous coronary intervention in small coronary vessels：from balloon angioplasty to drug eluting stent era［J］.Indian Heart J，2011，63(3)：228-233. 

[1]	. [J]. Acta Metallurgica Sinica, 2014, 34(10): 1032-1033.
[2]	. [J]. Acta Metallurgica Sinica, 2014, 34(9): 913-916.
[3]	BAI Xiao-juan，ZHAO Xin.. Aspirin and heart health in females. [J]. Acta Metallurgica Sinica, 2014, 34(1): 25-28.
[4]	YANG Mu-kun，BAI Wen-pei.. Sex hormone and heart health in females. [J]. Acta Metallurgica Sinica, 2014, 34(1): 12-14.
[5]	HAN Ya-ling，WANG Bin.. Pathophysiological characteristics of cardiovascular in females. [J]. Acta Metallurgica Sinica, 2014, 34(1): 10-11.
[6]	WANG Wei，QI Yue.. Prevalence trend of cardiovascular diseases in Chinese women. [J]. Acta Metallurgica Sinica, 2014, 34(1): 6-9.
[7]	LI Xian-kai,XU Ya-wei.. Interpretation of 2013 ACCF/AHA STEMI treatment guidelines. [J]. Acta Metallurgica Sinica, 2013, 33(4): 289-292.